ArticleHeliyon2022
Global academic output on COVID-19 and Guillain-Barre Syndrome: A bibliometric analysis.
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 5 citations in OpenAlex.
- Guillain-Barré syndrome and its variants during COVID-19 pandemic: a retrospective study in Iran.BMC neurology · 2026Article
- Global scientometric analysis ofVeterinary world · 2026Article
- Knowledge domain and emerging trends in post-stroke cognitive impairment: a bibliometric analysis.Frontiers in aging neuroscience · 2025Article
- Global Research Trends on Medial Meniscus Posterior Root Tear: A 20-Year Bibliometric Analysis.Journal of multidisciplinary healthcare · 2025Review
- Article
- Analysis and mapping of global scientific research on human monkeypox over the past 20 years.Veterinary world · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to bibliometrically analyze scientific publications on Guillain-Barré syndrome (GBS) related to COVID-19. A specialized search of the Scopus was used (December 2019 to February 2022). Collected publications were evaluated in Scival (Elsevier). The results were arranged in tables for presentation. We found 959 papers that were collected and the highest percentage of these belonged to the area of Neurology. Josef Finsterer was the author with the highest academic production, but Benedict Michael was the one with the highest impact worldwide. Although the Universidade Federal de São Paulo (Brazil) was the college with the highest scientific production, it was King's College London that reported the highest impact. Regarding the journals, the Journal of Neurology is the one with the highest worldwide production. In addition, an increase in first quartile publication and articles with national collaboration was reported. Scholarly output on COVID-19 and GBS have been increasing. Although national collaboration has the highest proportion of manuscripts, it is the international type that reported a greater impact, this would show a great interest on the part of researchers from all over the world regarding this topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.